Our Leadership: Imagination Over Iteration

Jeff Hawkins

President and Chief Executive Officer

Mr. Hawkins brings over 25 years of experience at the world’s leading life science and diagnostics companies as an accomplished business leader and inventor. Prior to Quantum-Si, he was President and Chief Executive Officer of Truvian Sciences, Inc. where he led the evolution of the company’s benchtop blood testing system from a product concept through technology feasibility and into late-stage development. Prior to Truvian, Mr. Hawkins led the Reproductive and Genetic Health Business Unit at Illumina, Inc., where he oversaw the rapid global growth of next-generation sequencing into new and emerging markets.

During his Illumina tenure, the business unit more than doubled in revenue and established clear market leadership across every major product line and geographic region. Before Illumina, Mr. Hawkins held roles of increasing responsibility across multiple functional areas for GenMark, Hologic, Third Wave Technologies and Abbott Laboratories. Mr. Hawkins holds a B.A. in Chemistry with honors from Concordia University and an MBA from Keller Graduate School of Management. He is co-inventor on more than 10 issued or pending patents spanning consumables, instrumentation, optics, manufacturing methods and designs.

Jeff Keyes

Chief Financial Officer

Mr. Keyes brings over 25 years of experience in senior financial positions providing financial leadership for emerging and evolving public and private companies. Previously, he served as the Chief Financial Officer of Spinal Elements, Inc., a private equity backed medical device company.  Prior to Spinal Elements, Mr. Keyes was the Chief Financial Officer of Custopharm, Inc., a private equity backed developer of generic sterile injectable pharmaceuticals, where he helped lead the company through rapid commercial growth and successful acquisition by Hikma Pharmaceuticals.  Prior to Custopharm, Mr. Keyes held a variety of leadership roles in life science companies in finance, accounting, and mergers and acquisitions support, and he started his career in public accounting. Mr. Keyes has also served on the board of directors of CNS Pharmaceuticals, Inc., a public clinical stage biotech company, since June 2018. Mr. Keyes earned a B.A. degree in accounting from Western Washington University and is a certified public accountant.

Beth Peralta

Vice President, Human Resources

Ms.  Peralta brings over 20 years of human resources experience across the biotech, medical device, pharmaceutical, and technology industries in both public and private companies. Previously, she served as the Head of Human Resources at Spinal Elements, Inc., a privately held medical device company, where she led the human resources function and partnered with executives on organizational strategy, talent management, leadership development, and employee engagement.

Prior to Spinal Elements, Ms. Peralta led Talent, Leadership Development and Engagement at Cue Health, Inc. where she established talent and learning programs through a period of significant growth. Prior to Cue Health, she held roles of increasing responsibility at Teradata, Thermo Fisher Scientific, and Johnson & Johnson.  

Ms. Peralta earned a B.A. Degree in Political Science from the University of San Diego, and a Human Resources Management Certification from University of California San Diego. She is also a Gallup-Certified Strengths Coach.

Ryan Miranovich

Vice President, Legal

Mr. Minarovich brings extensive legal experience advising life sciences and biotechnology companies across a broad range of corporate, commercial, strategic and compliance matters. Prior to joining Quantum-Si, he served as Assistant General Counsel and commercial legal lead at Maravai LifeSciences. 

Previously, Mr. Minarovich served as Director, Corporate Counsel at Thermo Fisher Scientific, where he oversaw legal matters for business units within the Genetic Sciences Division and advised on complex commercial transactions and strategic initiatives. Earlier in his career, Mr. Minarovich served as General Counsel of FIGmd, Inc. and practiced at Pillsbury Winthrop Shaw Pittman LLP, where he advised startups and high-growth companies on financings and other corporate matters. 

Throughout his career, he has focused on partnering closely with business teams to navigate complex legal and commercial matters and develop practical solutions that support growth and strategic objectives. 

Mr. Minarovich earned his law degree from Santa Clara University School of Law and attended Arizona State University and the University of California, Santa Cruz.